RMCM
ANGO icon

Reynders McVeigh Capital Management’s AngioDynamics ANGO Stock Holding History

Reynders McVeigh Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10,050
Closed -$113K – 150
2013
Q2 		$113K Buy
+10,050
New +$107K 0.03% 146

Other funds holding ANGO

RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Reynders McVeigh Capital Management's ANGO Position: Q3 2013 in Review

Reynders McVeigh Capital Management sold out of AngioDynamics (ANGO) in Q3 2013, closing a stake of 10,050 shares — an estimated $113K sold.

Reynders McVeigh Capital Management first reported a position in ANGO in Q2 2013 and held it in 1 quarter. The position peaked at $113K in Q2 2013. 91 funds tracked by Wall St. Rank hold ANGO as of Q3 2013.

  • Reynders McVeigh Capital Management reported no remaining AngioDynamics position as of Q3 2013 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 10,050 AngioDynamics shares in Q3 2013, an estimated $113K.
  • Reynders McVeigh Capital Management first reported a position in AngioDynamics in Q2 2013 and held it in 1 quarter.
  • Reynders McVeigh Capital Management's AngioDynamics position peaked at $113K in Q2 2013.
  • 91 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2013.

Based on Reynders McVeigh Capital Management's 13F filing for Q3 2013, filed 8 Nov 2013.